Document is current

Any future updates will be listed below

S-1 plus oxaliplatin versus capecitabine plus oxaliplatin for the first-line treatment of patients with metastatic colorectal cancer: updated results from a phase 3 trial

Crossref DOI link: https://doi.org/10.1186/1471-2407-14-883

Published Online: 2014-11-26

Published Print: 2014-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

About CrossMark